Transformative Innovations in Reproductive, Maternal, Newborn, and Child Health over the Next 20 Years

Cyril M Engmann; Sadaf Khan; Cheryl A Moyer; Patricia S Coffey; Zulfiqar A Bhutta

doi:10.1371/journal.pmed.1001969

Transformative Innovations in Reproductive, Maternal, Newborn, and Child Health over the Next 20 Years

PLoS Med. 2016 Mar 2;13(3):e1001969. doi: 10.1371/journal.pmed.1001969. eCollection 2016 Mar.

Authors

Cyril M Engmann^{1

2}, Sadaf Khan¹, Cheryl A Moyer³, Patricia S Coffey⁴, Zulfiqar A Bhutta^{5

6}

Affiliations

¹ Maternal, Newborn, Child Health and Nutrition, PATH, Seattle, Washington, United States of America.
² Department of Pediatrics, Neonatology, University of Washington, Seattle, Washington, United States of America.
³ Departments of Learning Health Sciences and Obstetrics & Gynecology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America.
⁴ Device/Tools Global Program, PATH, Seattle, Washington, United States of America.
⁵ Center for Global Child Health, Sick Kids, Toronto, Ontario, Canada.
⁶ Center of Excellence in Women and Child Health, Aga Khan University, Karachi, Pakistan.

Abstract

As part of the "Grand Convergence: Aligning Technologies and Realities in Global Health" Collection, Cyril Engmann and colleagues discuss promising innovations that have the potential to move the RMNCH agenda forward.

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Review

MeSH terms

Adult
Child Health Services / economics
Child Health Services / standards
Child Health Services / supply & distribution*
Child Health*
Child, Preschool
Female
Global Health
Health Services Accessibility
Health Services Needs and Demand
Humans
Infant Health*
Infant, Newborn
Maternal Health Services / economics
Maternal Health Services / standards
Maternal Health Services / supply & distribution*
Maternal Health*
Pregnancy
Quality Assurance, Health Care
Reproductive Health Services / economics
Reproductive Health Services / standards
Reproductive Health Services / supply & distribution*
Reproductive Health*

Grants and funding

PATH is a nongovernmental organization that does not make profit from its innovations. PATH staff (PC, SK) have ongoing funding from external donors to develop technologies in a couple of the innovation areas. These include projects on heat-stable oxytocin funded through USAID via the Saving Lives at Birth collaboration, and Chlorhexidine and Magnesium Sulphate funded through the UN Commission on Life-Saving Commodities. Previous funding (now completed) has also been received from the Merck for Mothers Alliance. This work is supported by a grant through the Bill & Melinda Gates Foundation to the University of California San Francisco, who commissioned this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.